Prostaglandins and cancer
- 31 December 1976
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 3 (4) , 217-225
- https://doi.org/10.1016/s0305-7372(76)80011-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- BREAST-CANCER OSTEOLYSIS, BONE METASTASES, AND ANTI-OSTEOLYTIC EFFECT OF ASPIRINThe Lancet, 1976
- INDOMETHACIN IN HYPERCALCÆMIAThe Lancet, 1975
- BREAST CANCER, PROSTAGLANDINS, AND BONE METASTASESThe Lancet, 1975
- INDOMETHACIN IN HYPERCALCÆMIAThe Lancet, 1975
- INDOMETHACIN IN BREAST CANCERThe Lancet, 1973
- EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2The Journal of Experimental Medicine, 1972
- Prostaglandin production by mouse fibrosarcoma cells in culture: Inhibition by indomethacin and aspirinBiochemical and Biophysical Research Communications, 1972
- THE BIOLOGICAL SIGNIFICANCE OF THE PROSTAGLANDINSAnnals of the New York Academy of Sciences, 1971
- Vasoactive substances in Kaposi's sarcomaCancer, 1971
- PROSTAGLANDIN SECRETION BY MEDULLARY CARCINOMA OF THE THYROID: A Possible Cause of the Associated DiarrhoeaThe Lancet, 1968